Form 8-K · Current report
Cardinal Health 8-K, filed Aug 11, 2026
- Filed
- CIK
- 0000721371
- Accession no.
- 0000721371-26-000037
Summary
Cardinal Health reported fourth-quarter fiscal 2026 revenue of $63.7 billion, up 6%, and non-GAAP diluted EPS of $2.91, up 40% including a one-time IEEPA tariff refund benefit, and guided fiscal 2027 non-GAAP diluted EPS to $12.40-$12.60, or 13%-15% growth. CEO Jason Hollar said all five operating segments grew profit double-digits and that the company enters fiscal 2027 with confidence.
Key points
- Cardinal Health reported fourth-quarter fiscal 2026 revenue of $63.7 billion, up 6%, and fiscal year 2026 revenue of $254.2 billion, up 14%.
- Fourth-quarter non-GAAP diluted EPS rose 40% to $2.91, including a one-time $0.31 benefit from recognition of IEEPA tariff refunds.
- Cardinal Health guided fiscal 2027 non-GAAP diluted EPS to $12.40-$12.60, or 13%-15% growth, and its board approved a $5.0 billion increase to the share repurchase authorization, bringing the total to $6.4 billion.
- Cardinal Health completed the tuck-in acquisition of Strive Medical, announced the acquisition of AdaptHealth's Diabetes Health business, renewed its wholesaler distribution contract with Kroger, and put in place a new $4.0 billion revolving credit facility.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 7.01Regulation FD Disclosure
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02: Results of Operations and Financial Condition On August 11, 2026, Cardinal Health, Inc. (the "Company") issued a news release announcing its results for the quarter and fiscal year ended June 30, 2026. A copy of the news release is included as Exhibit 99.1 to this report. Item 7.01: Regulation FD Disclosure During a webcast scheduled to be held at 8:30 a.m. Eastern time on August 11, 2026, the Company's Chief Executive Officer and Chief Financial Officer will discuss the Company's results for the quarter and fiscal year ended June 30, 2026 and outlook for the fiscal year ending June 30, 2027. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.